DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
El Miedany Y. et al.
The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases.
Am J Gastroenterol 2006;
101: 311-317.
We do not assume any responsibility for the contents of the web pages of other providers.